Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
187 hedge funds and large institutions have $557M invested in Portola Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 66 increasing their positions, 56 reducing their positions, and 67 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 56
1.39% less ownership
Funds ownership: 101.08% → 99.69% (-1.4%)
17% less funds holding
Funds holding: 224 → 187 (-37)
49% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 67
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
70% less capital invested
Capital invested by funds: $1.88B → $557M (-$1.32B)
75% less call options, than puts
Call options by funds: $2.4M | Put options by funds: $9.78M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$34.3M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$10.6M |
| 3 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$10.1M |
| 4 |
Renaissance Technologies
New York
|
+$9.68M |
| 5 |
Goldman Sachs
New York
|
+$8.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$32.9M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$24.1M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$15M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.9M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$14.5M |
PTLA Hedge Fund Activity: Q1 2020 in Review
187 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q1 2020, worth a combined $557M — down 70% from $1.88B a quarter earlier.
Sellers outnumbered buyers: 67 funds closed out of PTLA and 34 opened new positions — a net loss of 33 holders — while 56 trimmed existing stakes and 66 added.
The largest buyer was William Blair Investment Management, adding an estimated $34.3M. The largest seller was Franklin Resources, exiting entirely with an estimated $32.9M sold.
- 187 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q1 2020, down from 224 in Q4 2019.
- Funds reported $557M of Portola Pharmaceuticals, Inc. stock for Q1 2020, down 70% quarter-over-quarter.
- 34 funds opened new Portola Pharmaceuticals, Inc. positions in Q1 2020 and 67 closed out, a net change of -33 holders.
- The largest Portola Pharmaceuticals, Inc. buyer in Q1 2020 was William Blair Investment Management, an estimated $34.3M added.
- The largest Portola Pharmaceuticals, Inc. seller in Q1 2020 was Franklin Resources, an estimated $32.9M sold.
Based on aggregated 13F filings for Q1 2020.